Skip to main content
HealthReportedLow
1.9

Croatian biotech vitaLABS advances VB-7 anti-aging drug for dogs

Zagreb-based vitaLABS is developing VB-7, a molecule aimed at healthier aging in dogs, with formulations at the core of the project. The development is at an early stage, with no clinical data or timeline disclosed. This is a niche veterinary biotech development with limited immediate market or geopolitical impact.

Poslovni Dnevnik1 day agoHRCredibility 18%View source

Score Breakdown

Mosaic Score1.9
Model confidence0.1
Significance0.1
Source credibility0.2
Source

Related signals

8 found